Predictions
NeuroMetrix Inc.
Start price
Target price
Perf. (%)
€37.16
01.05.17
01.05.17
€50.51
12.05.17
12.05.17
646.50%
12.05.17
12.05.17
Molina Healthcare
Start price
Target price
Perf. (%)
€46.21
02.05.17
02.05.17
€52.32
02.05.17
02.05.17
14.70%
02.05.17
02.05.17
Could be worthwhile Investment >10% per year
Molina Healthcare
Start price
Target price
Perf. (%)
€46.16
02.05.17
02.05.17
€52.32
02.05.17
02.05.17
14.03%
02.05.17
02.05.17
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€1,729.1
24.03.17
24.03.17
€1,623.6
24.03.17
24.03.17
-12.86%
24.03.17
24.03.17
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€136.85
21.11.16
21.11.16
€150.00
21.02.17
21.02.17
10.28%
21.02.17
21.02.17
Veeva Systems A
Start price
Target price
Perf. (%)
€36.36
31.08.16
31.08.16
€38.79
23.11.16
23.11.16
11.36%
23.11.16
23.11.16
Could be worthwhile Investment >10% per year
Ekso Bionics Holdings Inc.
Start price
Target price
Perf. (%)
€50.51
13.09.16
13.09.16
€60.00
28.09.16
28.09.16
20.94%
28.09.16
28.09.16
Community Health Systems Inc.
Start price
Target price
Perf. (%)
€10.08
14.09.16
14.09.16
€10.37
16.09.16
16.09.16
9.85%
16.09.16
16.09.16
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€10.64
21.07.16
21.07.16
€11.71
19.08.16
19.08.16
10.34%
19.08.16
19.08.16
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€61.88
02.06.16
02.06.16
€72.16
13.07.16
13.07.16
17.49%
13.07.16
13.07.16
Cantel Medical Corp.
Start price
Target price
Perf. (%)
€63.65
08.06.16
08.06.16
€64.04
08.06.16
08.06.16
0.75%
08.06.16
08.06.16
Luna Innovations Inc.
Start price
Target price
Perf. (%)
€0.96
19.05.16
19.05.16
€1.04
03.06.16
03.06.16
8.49%
03.06.16
03.06.16
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€271.44
05.05.16
05.05.16
€324.00
19.05.16
19.05.16
31.03%
19.05.16
19.05.16
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€56.83
27.02.16
27.02.16
€64.94
20.04.16
20.04.16
15.27%
20.04.16
20.04.16
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation